Neuronetics (STIM) approves 2026 annual cash incentives for CEO and top executives

Rhea-AI Filing Summary

FAQ

Filing Exhibits & Attachments

8-K Event Classification

What executive bonuses did Neuronetics (STIM) approve in February 2026?

When will Neuronetics (STIM) pay the approved executive cash incentives?

Which Neuronetics (STIM) committee approved the 2026 executive incentive awards?

How much is Neuronetics (STIM) paying its CEO in annual cash incentive for 2026?

What cash incentive did Neuronetics (STIM) award its CFO for 2026?

Filing Impact

(Moderate)

Filing Sentiment

(Neutral)

Form Type

8-K

Neuronetics, Inc. reported that its Board and Compensation Committee approved annual cash incentive awards for three senior executives. On February 23, 2026, the Compensation Committee approved cash incentives of $73,216.44 for Executive Vice President and Chief Financial Officer Steven E. Pfanstiel and $163,383.75 for Executive Vice President, Chief Legal Officer, and Corporate Secretary W. Andrew Macan.

On the same date, the Board, following the Compensation Committee’s recommendation, approved an annual cash incentive award of $412,775.95 for President and Chief Executive Officer Keith J. Sullivan. The company stated that these cash incentive awards will be paid on or about March 13, 2026.

Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers

1 item

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers Governance

Key personnel changes including departures, elections, or appointments of directors and executive officers.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Understanding 8-K Material Events →

02/25/2026 - 04:45 PM

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): February 23, 2026

NEURONETICS, INC.

(Exact name of registrant as specified in its charter)

Delaware

001-38546

33-1051425

(State or other jurisdiction

of incorporation)

(Commission

File Number)

(IRS Employer

Identification No.)


3222 Phoenixville Pike, Malvern, PA		19355
(Address of Principal Executive Offices)		(Zip Code)

Registrant’s telephone number, including area code: (877) 600-7555

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading

Symbol

Name of each exchange

on which registered

Common Stock, $0.01 par value

STIM

The Nasdaq Global Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 5.02.

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

(e) On February 23, 2026, the Compensation Committee (the “Compensation Committee”) of the Board of Directors (the “Board”) of Neuronetics, Inc. (the “Company”) approved annual cash incentive compensation awards for Steven E. Pfanstiel, the Company’s Executive Vice President, Chief Financial Officer, and Treasurer, and W. Andrew Macan, the Company’s Executive Vice President, Chief Legal Officer, and Corporate Secretary, in the amounts of $73,216.44 and $163,383.75, respectively. Also on February 23, 2026, at the recommendation of the Compensation Committee, the Board approved an annual cash incentive compensation award for Keith J. Sullivan, the Company’s President and Chief Executive Officer, in the amount of $412,775.95. The awards will be paid on or about March 13, 2026.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Source: View Original Filing on SEC EDGAR

Neuronetics approved annual cash incentive awards for three senior executives. CFO Steven E. Pfanstiel will receive $73,216.44, CLO W. Andrew Macan $163,383.75, and CEO Keith J. Sullivan $412,775.95. These awards represent their annual cash incentives for the year.

Neuronetics plans to pay the approved executive cash incentive awards on or about March 13, 2026. This payment timing applies to the bonuses granted to CEO Keith Sullivan, CFO Steven Pfanstiel, and Chief Legal Officer W. Andrew Macan as part of their annual incentive compensation.

The Compensation Committee of Neuronetics’ Board approved annual cash incentive awards for Steven E. Pfanstiel and W. Andrew Macan on February 23, 2026. The Board, following the committee’s recommendation, separately approved the 2026 annual cash incentive for President and CEO Keith J. Sullivan the same day.

Neuronetics’ President and Chief Executive Officer, Keith J. Sullivan, will receive an annual cash incentive award of $412,775.95. The Board approved this amount on February 23, 2026, based on the recommendation of the Compensation Committee, with payment expected on or about March 13, 2026.

Neuronetics awarded its Executive Vice President, Chief Financial Officer, and Treasurer, Steven E. Pfanstiel, an annual cash incentive of $73,216.44. The Compensation Committee approved this award on February 23, 2026, as part of the company’s executive incentive compensation program for that year.

NEURONETICS, INC.

Date: February 25, 2026

/s/ W. Andrew Macan

W. Andrew Macan

EVP, Chief Legal Officer, and Corporate Secretary

3 documents